Literature DB >> 11177159

Plesiomonas shigelloides infection in Hong Kong: retrospective study of 167 laboratory-confirmed cases.

T Y Wong1, H Y Tsui, M K So, J Y Lai, S T Lai, C W Tse, T K Ng.   

Abstract

OBJECTIVE: To study the epidemiological, clinical, and microbiological features of Plesiomonas shigelloides infection in Hong Kong.
DESIGN: Retrospective study.
SETTING: Infectious Disease Unit of a district hospital, Hong Kong. PATIENTS: Patients with laboratory-confirmed cases of Plesiomonas shigelloides infection between 1 January 1995 and 31 December 1998. MAIN OUTCOME MEASURES: Epidemiological and clinical data, antibiotic sensitivity, and clinical outcome.
RESULTS: There was an increasing trend in the number of isolates of Plesiomonas shigelloides obtained and the prevalence of the bacterium. A total of 197 isolates were obtained from 188 patients, and most isolates (172; 87.3%) were obtained during the summer. Clinical and epidemiological data were available for 167 patients (85 males, 82 females). Patient age ranged from 1 month to 95 years; the mean and median ages of the patients older than 15 years were 51.0 and 40.5 years, respectively (n=132). Only 35 (21.0%) of the 167 patients had a history of travel outside Hong Kong, whereas 21 (12.6%) had a history of consuming seafood or uncooked food; 39 (23.4%) had underlying medical conditions. Most patients (165; 98.8%) had symptoms of Plesiomonas shigelloides infection. Nine (5.4%) patients had had chronic diarrhoea for more than 2 weeks; watery and bloody diarrhoea was discharged by 122 (73.1%) and 42 (25.1%) of the patients, respectively. All 197 Plesiomonas shigelloides isolates were sensitive to ofloxacin, or levofloxacin and ceftriaxone. Resistance or partial resistance was recorded for ampicillin (72%), tetracycline (67%), co-trimoxazole (12%), and chloramphenicol (5%). The majority of patients (142/167; 85.0%) had self-limiting cases of infection, but 25 patients were given antibiotics for more severe symptoms at the time of presentation; there were two deaths.
CONCLUSIONS: The occurrence of Plesiomonas shigelloides infection in Hong Kong is increasing, although most cases of are self-limiting.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11177159

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  7 in total

Review 1.  Plesiomonas shigelloides Revisited.

Authors:  J Michael Janda; Sharon L Abbott; Christopher J McIver
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

Review 2.  Acute gastroenteritis in children : what role for antibacterials?

Authors:  Nopaorn Phavichitr; Anthony Catto-Smith
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

3.  Some properties of Plesiomonas shigelloides treated with aminoglycosides.

Authors:  A Hostacká; I Ciznár
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

4.  A global bibliometric analysis of Plesiomonas-related research (1990 - 2017).

Authors:  Temitope Cyrus Ekundayo; Anthony I Okoh
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

5.  Genome Sequence of Plesiomonas shigelloides Strain 302-73 (Serotype O1).

Authors:  Núria Piqué; Eleonora Aquilini; Tyler Alioto; David Miñana-Galbis; Juan M Tomás
Journal:  Genome Announc       Date:  2013-06-27

6.  Plesiomonas shigelloides infection in Southeast China.

Authors:  Xiao Chen; Yu Chen; Qing Yang; Haishen Kong; Fei Yu; Dongsheng Han; Shufa Zheng; Dawei Cui; Lanjuan Li
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

7.  Distinction between Antimicrobial Resistance and Putative Virulence Genes Characterization in Plesiomonas shigelloides Isolated from Different Sources.

Authors:  Samy Selim; Mohammed S Almuhayawi; Shadi Ahmed Zakai; Ahmed Attia Salama; Mona Warrad
Journal:  Antibiotics (Basel)       Date:  2022-01-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.